Browse the evidence

Performing 60 minutes of moderate-intensity treadmill exercise induces significant circadian phase shifts in humans, with large phase delays occurring when exercise is performed between 7:00 pm and 10:00 pm, and large phase advances occurring when exercise is performed at 7:00 am or between 1:00 pm and 4:00 pm.

If you need to adjust your sleep schedule, time your 60-minute moderate exercise (where you can talk but not sing) strategically. To fall asleep earlier (phase advance), exercise between 7:00 am and 4:00 pm. To stay up later (phase delay), exercise between 7:00 pm and 10:00 pm. Avoid exercising around 4:00 pm or 2:00 am if you want to minimize shifts, as these times produce minimal effects.

Sibutramine (5-20 mg/day) produces significant weight loss and metabolic improvements in obese patients with controlled hypertension, but causes small, statistically significant increases in blood pressure and heart rate.

Sibutramine can help obese patients with controlled hypertension lose weight and improve metabolic markers, but it requires careful monitoring of blood pressure and heart rate. The benefits of weight loss generally outweigh the small increases in vital signs for this specific population.

Consumption of Western diet components (hyperglycemic carbohydrates, milk/dairy, saturated/trans fats) promotes acne vulgaris by activating insulin/IGF-1 and mTORC1 signaling, which suppresses FoxO1 and upregulates lipogenic transcription factors (SREBP-1c, PPARγ), leading to hyperseborrhea and comedogenesis.

To reduce acne risk, prioritize a diet low in refined carbohydrates, milk, dairy protein supplements, and saturated/trans fats. Instead, focus on a paleolithic-like diet rich in vegetables and fish. Consider supplements with plant-derived mTORC1 inhibitors and omega-3 PUFAs to support skin health.

Peptide YY (PYY) is a satiety signal released from the gut after meals that inhibits food intake and promotes weight loss, with effects observed in both lean and obese humans.

PYY is a hormone released by the gut after eating, especially when lipids and carbohydrates are present in the lower intestine. It signals the brain to stop eating. While its effect is modest, it is a key natural mechanism for satiety that works even in obese individuals.

Ghrelin is the first gut hormone shown to stimulate food intake, and its levels peak before meals, acting as a hunger signal.

Ghrelin is a hormone that signals hunger to the brain. Its levels rise before meals, stimulating appetite and gastric emptying. Understanding this pre-meal hunger signal can help individuals anticipate and manage their food intake more effectively.

Diet-induced weight loss reduces postprandial levels of anorexigenic gut hormones (GLP-1, PYY, CCK), which increases appetite and promotes weight regain, whereas exercise training tends to increase or maintain these hormones, supporting satiety and weight maintenance.

If you lose weight through dieting, expect your hunger hormones (GLP-1, PYY) to drop, making you hungrier and increasing the risk of regaining weight. To counter this, incorporate regular exercise, which appears to help maintain or increase these satiety hormones, thereby supporting weight maintenance.

Obese individuals exhibit attenuated postprandial responses of satiety hormones (GLP-1, PYY) compared to lean individuals, which correlates with lower subjective fullness and potentially contributes to overconsumption.

Obese individuals may experience less fullness after meals due to blunted satiety hormone responses. This is a biological factor, not just a lack of willpower. Strategies that naturally boost these hormones (like high-protein/fat meals or exercise) may help.

Concurrent strength and endurance training interferes with maximal strength development when both modalities engage the same muscle groups, primarily due to antagonistic intracellular signaling where AMPK activation inhibits mTOR.

If your primary goal is maximizing strength, be aware that adding endurance training (like running or cycling) in the same session or on the same days can blunt your strength gains. This is due to conflicting signals in your muscle cells. To fix this, separate your strength and endurance sessions by at least 6-8 hours, or prioritize one modality on specific days.

Type 2 diabetes mellitus (T2DM) acts as an independent pathogenic factor for osteoarthritis (OA) progression and arthroplasty complications through mechanisms of oxidative stress, advanced glycation end-products (AGEs), and insulin resistance, separate from mechanical load.

If you have Type 2 Diabetes and joint pain, treating the diabetes is part of treating the arthritis. High blood sugar and insulin resistance actively damage joint tissue through inflammation and stiffness (AGEs), independent of how much you weigh. Optimize glucose control to potentially slow joint degradation.

In healthy, trained men, a single exercise session expending 1,100 kcal or more at 70% VO2max significantly increases HDL-C concentrations 24 hours post-exercise, whereas sessions expending 800 kcal do not.

If you are a trained male looking to boost your HDL cholesterol, a single run burning 1,100 calories at 70% of your max effort will significantly raise your HDL levels the next day. A shorter run (800 calories) may lower triglycerides but won't significantly raise HDL. Aim for the higher energy expenditure to get the HDL benefit.

A single exercise session expending 800 kcal or more significantly decreases triglyceride (TG) and VLDL-C concentrations 24 hours post-exercise in trained men.

To lower your triglycerides, you need to burn at least 800 calories in a single exercise session. This effect is seen 24 hours after the workout. Higher energy expenditure (1,100+ kcal) yields greater reductions.

A single exercise session expending 1,300 kcal or more significantly decreases LDL-C concentrations immediately and 24 hours post-exercise in trained men.

To see a reduction in LDL cholesterol, you likely need to burn 1,300 calories or more in a single session. This reduction is immediate and may persist for 24 hours if the expenditure is 1,500 kcal.

Recombinant leptin therapy successfully treats obesity in individuals with inborn leptin deficiency by reducing hyperphagia and promoting substantial fat mass loss.

If you have been diagnosed with inborn leptin deficiency, recombinant leptin therapy is a proven, effective treatment that can significantly reduce fat mass and normalize eating behaviors by addressing the underlying hormonal deficit.

Hyperinsulinemia promotes obesity by inhibiting lipolysis and promoting lipogenesis at insulin concentrations lower than those required to inhibit gluconeogenesis.

Focus on keeping your fasting insulin low to prevent fat gain. Even modest increases in insulin (e.g., from doubling your baseline) can shut down fat burning (lipolysis) and start fat storage (lipogenesis) before your blood sugar regulation is even affected. This suggests that frequent snacking or high-carb meals, which keep insulin elevated, are more likely to cause weight gain than occasional high-sugar meals that spike glucose but clear quickly.

Testosterone administration increases muscle power and function, but its use is limited by potential side effects, particularly cardiovascular events and prostate malignancy risk, which vary by administration route.

Testosterone can improve muscle power and function, but it is not a first-line treatment due to potential side effects. If considered, the route of administration matters: oral testosterone may carry higher cardiovascular risks compared to transdermal or injection methods. Consult a physician to weigh benefits against risks.

In very old community-living men, higher baseline serum IGF-1 levels predict smaller losses in fat-free mass (FFM) over a 2-year period, suggesting anabolic protection against sarcopenia.

If you are an older man concerned about muscle loss, your natural hormone levels (specifically IGF-1) play a crucial role in preserving muscle mass. While you should still maintain physical activity and adequate protein, this research suggests that hormonal decline is a major driver of sarcopenia in this age group. Monitoring health markers and discussing hormonal health with a physician may be as important as lifestyle habits.

Exercise training improves endothelial function and nitric oxide (NO) bioavailability by upregulating eNOS activity through shear stress mechanisms, thereby reducing peripheral resistance and improving vascular perfusion.

Regular aerobic exercise helps keep your blood vessels flexible and healthy by increasing nitric oxide production, which helps regulate blood pressure and blood flow.

Exercise training mobilizes endothelial progenitor cells (EPCs) and mesenchymal stem cells (MSCs) from the bone marrow, promoting vascular regeneration and endothelial repair.

Exercise helps your body repair blood vessel damage by releasing stem cells from your bone marrow that can fix the lining of your arteries.

Small increases in skin temperature (0.4°C within the 31-35°C range) can shorten sleep latency and promote deeper sleep without altering core body temperature.

You do not need to significantly heat your room or body to fall asleep faster. A subtle warming of your skin (via bedding) by just 0.4°C is sufficient to shorten sleep latency. This is particularly useful for elderly individuals or insomniacs who may have deficits in normal thermoregulation.

Sarcopenic obesity drives cardiovascular disease and mortality through mechanisms of chronic low-grade inflammation, insulin resistance, and lipotoxicity, creating a vicious cycle with cardiovascular conditions.

Understanding that fat and muscle loss interact to cause inflammation and heart risk highlights why treating both is crucial. Managing inflammation and insulin sensitivity through lifestyle can break this cycle.

Daily intake of Lactobacillus reuteri (2x10^10 cells) for 4 weeks increases glucose-stimulated GLP-1 and GLP-2 secretion, which in turn increases insulin and C-peptide secretion in glucose-tolerant humans.

Taking Lactobacillus reuteri (20 billion cells twice daily) for a month can boost your body's production of GLP-1 and GLP-2 hormones after meals, which helps your pancreas release more insulin. However, this does not make your body more sensitive to insulin or help you lose weight if you are already healthy. It is a specific hormonal boost, not a general metabolic fix.

Ethinyl estradiol is strongly associated with an increased risk of cardiovascular events and should be avoided in transgender women; oral and transdermal estradiol are preferred.

Transgender women should avoid ethinyl estradiol due to its strong association with blood clots and cardiovascular events. Instead, use oral or transdermal estradiol, which are safer and preferred formulations.

Leptin repletion following weight loss (maintenance phase) reverses metabolic adaptations (hypometabolism, hyperphagia) and aids in sustaining weight loss, but does not significantly lower the body weight set-point.

After losing weight, your body fights back with increased hunger and slower metabolism. Leptin therapy can help reverse these specific biological drivers during the maintenance phase, making it easier to keep the weight off, though it is not a weight-loss drug itself.

Obesity causes a significant reduction in circulating adiponectin levels, which contributes to insulin resistance, metabolic syndrome, and increased cancer risk.

If you have excess body fat, your body naturally produces less of this protective hormone, which makes you more resistant to insulin and prone to inflammation. This is a biological feedback loop, not a character flaw. Addressing the underlying adiposity through sustainable lifestyle changes can help restore normal adiponectin levels and improve metabolic health.